Argo Biopharma Is Said to Pick Banks for Hong Kong IPO
PositiveFinancial Markets

Argo Biopharma Is Said to Pick Banks for Hong Kong IPO
Argo Biopharmaceutical Co., a Chinese biotech firm, is gearing up for an initial public offering (IPO) in Hong Kong, with plans to raise several hundred million dollars. This move is significant as it highlights the growing interest and investment in the biotech sector, particularly in Asia, which could lead to advancements in healthcare and innovation.
— via World Pulse Now AI Editorial System







